does tirzepatide affect your heart Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role of | Cardiovascular Diabetology Mounjaro, Zepbound Lowers Risk of

A clinical study of orally collagen intake and evalution of the effects on human skin physiological properties

Gastrointestinal adverse events Compared with placebo, all doses of tirzepatide and semaglutide demonstrated an increase in the risk for nausea (ESM Fig

Slower gut motility means things move less

Treatment with MOUNJARO 10 mg and 15 mg once weekly for 52 weeks resulted in a statistically significant reduction in HbA1c compared with insulin glargine once daily (see Table 7)

Digestive effects such as nausea, vomiting, diarrhea, constipation, appetite changes, and abdominal discomfort are commonly discussed with incretin-based therapies

For everything else, there's a distinction worth understanding